BIOMAT Database Logo BIOMAT Database Logo

[In vitro study of the effectiveness of a cefamandole-tobramycin combination]. 1986

T M Konkoly, and E Bán, and G Apostolos, and F Lakatos, and Z Magyar, and E Nagy

UI MeSH Term Description Entries
D002435 Cefamandole Semisynthetic wide-spectrum cephalosporin with prolonged action, probably due to beta-lactamase resistance. It is used also as the nafate. Cephamandole,Compound 83405
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D014031 Tobramycin An aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the PSEUDOMONAS species. It is a 10% component of the antibiotic complex, NEBRAMYCIN, produced by the same species. Nebramycin Factor 6,Brulamycin,Nebcin,Nebicin,Obracin,Tobracin,Tobramycin Sulfate,Sulfate, Tobramycin
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

T M Konkoly, and E Bán, and G Apostolos, and F Lakatos, and Z Magyar, and E Nagy
[In vivo evaluation of the effectiveness of a cefamandole-tobramycin combination].
November 1986, Orvosi hetilap,
T M Konkoly, and E Bán, and G Apostolos, and F Lakatos, and Z Magyar, and E Nagy
In vitro synergy of cefamandole-tobramycin combinations.
January 1977, The Yale journal of biology and medicine,
T M Konkoly, and E Bán, and G Apostolos, and F Lakatos, and Z Magyar, and E Nagy
Therapy of staphylococcal infections with cefamandole or vancomycin alone or with a combination of cefamandole and tobramycin.
January 1983, Antimicrobial agents and chemotherapy,
T M Konkoly, and E Bán, and G Apostolos, and F Lakatos, and Z Magyar, and E Nagy
The lack of inactivation of tobramycin by cefazolin, cefamandole, and moxalactam in vitro.
September 1985, Drug intelligence & clinical pharmacy,
T M Konkoly, and E Bán, and G Apostolos, and F Lakatos, and Z Magyar, and E Nagy
[In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].
June 1984, Pathologie-biologie,
T M Konkoly, and E Bán, and G Apostolos, and F Lakatos, and Z Magyar, and E Nagy
[Cefamandole as prophylactic A.B. in abdominal surgery. Comparative study of cefamandole versus clindamycin/tobramycin (author's transl)].
January 1980, Acta chirurgica Belgica,
T M Konkoly, and E Bán, and G Apostolos, and F Lakatos, and Z Magyar, and E Nagy
Effect of cefamandole nafate on the toxicity of tobramycin.
October 1977, Antimicrobial agents and chemotherapy,
T M Konkoly, and E Bán, and G Apostolos, and F Lakatos, and Z Magyar, and E Nagy
A multicentre study of the susceptibility of a variety of bacteria to cephalothin, cefamandole, tobramycin and gentamicin.
November 1977, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
T M Konkoly, and E Bán, and G Apostolos, and F Lakatos, and Z Magyar, and E Nagy
A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients.
October 1979, The American journal of medicine,
T M Konkoly, and E Bán, and G Apostolos, and F Lakatos, and Z Magyar, and E Nagy
[Clinical efficacy and safety of the cefamandole-tobramycin combination in the prevention and treatment of surgical infections in high-risk patients].
December 1983, Chirurgia e patologia sperimentale,
Copied contents to your clipboard!